Ignite Creation Date:
2024-05-06 @ 3:28 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04646044
Status:
COMPLETED
Last Update Posted:
2024-03-12
First Post:
2020-11-14
Brief Title:
A Placebo Controlled Trial of Bempegaldesleukin BEMPEG NKTR-214 With Standard of Care in Patients With Mild COVID-19
Sponsor:
Organization:
Nektar Therapeutics